Effect of Quinolones Against Slowly Growing Bacteria --;The Postantibiotic Effect of Ciprofloxacin --;The Effects of Different Types of Antimicrobial Agents on Plasma Endotoxin Activity in Gram-Negative Bacterial Infection --;Dose-Finding Investigations of Intravenous Ciprofloxacin in a Pharmacodynamic Model --;The Relationship Between Ciprofloxacin Blood Concentrations, MIC Values, Bacterial Eradication, and Clinical Outcome in Patients with Nosocomial Pneumonia --;Efficacy and Safety of Ciprofloxacin in Various Intravenous Dosages --;Intravenous Ciprofloxacin Versus Imipenem/Cilastatin in the Treatment of Severe Pneumonia --;Conversion of Intravenous to Oral Ciprofloxacin: Observing the 'Like-to-Like' Phenomenon --;Therapeutic Use of Quinolones in Oncology --;Ciprofloxacin in Neutropenic Host Infection --;Intravenous Ciprofloxacin for the Treatment of Lower Respiratory Tract Infections: Preliminary Results --;Integrated Safety Profile of Intravenous Ciprofloxacin.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
International Symposium, Salzburg, September 1993
عنوان اصلی به زبان دیگر
عنوان اصلي به زبان ديگر
International Symposium, Salzburg, September 1993
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Internal medicine.
موضوع مستند نشده
Medicine.
موضوع مستند نشده
Toxicology.
رده بندی کنگره
شماره رده
RM666
.
C5418
نشانه اثر
E358
1994
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )